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The spatial and temporal deployment of HOX homeobox
genes along the spinal axis and in limb buds during fetal
development is a key program in embryonic pattern
formation. Although we have previously reported that
several of the HOX homeobox genes are expressed during
murine skin development, there is no information about
developmental expression of HOX genes in human skin.
We have now used reverse transcriptase polymerase chain
reaction, in conjunction with a set of degenerate oligo-
nucleotide primers, to identify a subset of HOX genes
that are expressed during human fetal skin development.
In situ hybridization analyses demonstrated that there
were temporal and spatial shifts in expression of these
genes. Strong HOXA4 expression was detected in the
Human skin is comprised of a self-renewing epidermisderived from ectodermal tissue, and an underlyingdermis, which is of mesodermal origin. There isincreasing evidence that BMP-4 (Nohno et al, 1995a),and other signaling molecules such as sonic hedgehog
(Nohno et al, 1995b), TGF-α (Luetteke et al, 1993; Mann et al, 1993),
and EGF (Miettinen et al, 1995; Murillas et al, 1995), play important
inductive roles in epithelial-mesenchymal signaling during skin devel-
opment and hair formation. It has been hypothesized that a set of
transcription factors must mediate the effects of these putative morpho-
gens to regulate skin-specific gene transcription. In this regard, the
Lef-1 transcription factor has been shown to play a role in whisker
and hair formation (van Genderen et al, 1994; Zhou et al, 1995);
however, the molecular mechanisms that regulate skin and hair
development remain largely unknown.
The HOX homeobox genes appear to be candidates for the regulation
of skin development. These master developmental regulatory genes
encode proteins that contain a conserved 60 amino acid, DNA binding
homeodomain and function as transcription factors (Gehring et al,
1994). The 39 human homeobox genes are arrayed in four parallel
chromosomal clusters such that individual genes from each loci (e.g.,
HOXA4, HOXB4, HOXC4, and HOXD4) show a high degree of
homology within their putative homeodomains. The HOX homeo-
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basal cell layers of 10 wk fetal epidermis and throughout
the epidermis and dermis of 17 wk skin, whereas weak
signal was present in the granular layer of newborn
and adult skin. The expression patterns of HOXA5 and
HOXA7 were similar, but their expression was weaker.
In situ hybridization analysis also revealed strong HOXC4
and weaker HOXB7 expression throughout fetal develop-
ment, whereas HOXB4 was expressed at barely detectable
levels. Differential HOX gene expression was also
observed in developing hair follicles, and sebaceous and
sweat glands. None of the HOX genes examined were
detected in the adult dermis. Key words: dermis/epidermis/
gene regulation/homeodomain. J Invest Dermatol 110:110–
115, 1998
domain proteins appear to regulate the formation of multiple structures
along various body axes such as the spinal cord, and limbs (Krumlauf,
1994). We (Detmer et al, 1993; Mathews et al, 1993) and others
(Bieberich et al, 1991; Reiger et al, 1994) have previously detected
expression of several of the Hox genes, particularly those in the Hox-
b cluster, in fetal and adult murine skin. In addition, there have been
several reports of spatially restricted expression of Hox genes in
developing murine (Bieberich et al, 1991; Kanzler et al, 1994) and
chicken skin (Chuong et al, 1990). Based on these studies and the
well-recognized role of homeodomain proteins in development, Scott
and Goldsmith proposed that the HOX homeobox genes play a major
regulatory role in human skin development (Scott and Goldsmith,
1993). Until now, however, there have not been studies on the spatial
and temporal expression of HOX genes in developing human skin.
We report here the use of a reverse transcriptase polymerase chain
reaction (RT-PCR) based approach to identify which of the 39 human
HOX genes are expressed in first and second trimester human fetal
skin and which are expressed in adult skin. Only a small subset of
HOX genes were detected using this method. In situ hybridization
analysis revealed spatial and temporal changes in the expression of these
genes within both the developing epidermis and the dermis, as well as
in hair follicles.
MATERIALS AND METHODS
Tissue samples Tissue samples were obtained under NIH guidelines and
after approval of the University of California San Francisco Committee on
Human Research. Tissue was fixed in 4% paraformaldehyde for 4 h, dehydrated
in graded ethanol, and embedded in paraffin. For some tissues, half was frozen
in solution D (see below) for subsequent RNA isolation. Following informed
consent newborn and adult skin samples were obtained from the margins of
specimens from elective surgery.
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Dermo–epidermal separation Five samples of second trimester fetal scalp
skin (18–22 wk) and five samples of adult skin (50–65 y) were subjected to
dermal/epidermal separation by exposure of full thickness skin samples to dry
heat (60°C for 60 s) (Holleran et al, 1992). The epithelium was then scraped
off the dermis and placed in a separate container for RNA isolation.
RNA isolation Total RNA was isolated from fetal, neonatal, and adult skin
using the guanidinium thiocyanate method (Chomczynski et al, 1987). Skin
from the scalp, back, or limbs was homogenized in solution D (4 M
guanidinium thiocyanate, 25 mM sodium citrate, pH 7, 0.5% sarcosyl, 0.1% 2-
mercaptoethanol), and RNA was separated from DNA and protein by extraction
with acid phenol:chloroform:isoamyl alcohol (50:49:1). RNA concentrations
were estimated by the optical density at 260 nM, and RNA was stored in 70%
ethanol at –70°C.
RT-PCR RT-PCR was used to survey for HOX gene expression in each
sample. We used a protocol that included two polymerase chain reaction (PCR)
amplifications (Sauvageau et al, 1994). First, amplified cDNA representing total
mRNA was synthesized from each tissue RNA. A subsequent PCR amplification
using degenerate primers designed against all 391 HOX genes permitted their
identification by cloning and sequencing of the PCR reaction products. The
first strand cDNA was synthesized by adding total RNA (1 µg) to 103reverse
transcriptase buffer, dNTP, Superscript II reverse transcriptase (Gibco BRL,
Gaithersburg, MD), and an oligo dT primer: (59-CATGTCGTCCAGGCCG-
CTCTGGACAAAATATGAATTC (T)21–39). Following reverse transcription
and phenol/chloroform extraction, a 59 polyA tail was added to the cDNA
using terminal transferase. The same oligo dT primer was then re-added to the
solution (1 µg per µl) and PCR was performed (94°C, 2 min; 55°C, 3 min;
72°C, 10 min) for 35 cycles.
The amplified cDNA mixtures were screened using a set of degenerate HOX
gene primers derived from two conserved regions of the homeobox, separated
by 118 nt: (59-GA (G/A) (T/C)T (G/A/T)GA (A/G) (C/A/G) (G/A) (G/A/
C)GA (A/G)T (A/T) (T/C)-39) and (59-NC (G/T) (A/G)TT (T/C)TG (A/
G)AACCANA (C/T)-39). A Hot Wax PCR kit (10 3 buffer pH 5 10.0 and
1.5 MgCl beads) (Invitrogen, La Jolla, CA) was used to maximize the PCR
reaction (94°C, 2 min; 48°C, 2.5 min; and 72°C, 3 min) for 32 cycles. This
procedure produced a 118 bp band that was detected on a 2% agarose gel
(FMC, Rockland, ME) and that contained amplified products reflecting the
homeobox gene transcripts present in each tissue sample.
In order to identify the various homeobox cDNA derived from each sample,
the 118 bp DNA fragments were cut from the gels, purified (Bio 101, Vista,
CA), and ligated into the T/A PcRII vector (Invitrogen). Insert-containing
clones were sequenced using 35S-ATP and the Sanger dideoxy method (Promega,
Madison, WI). Sequences were identified by comparison to the known 38
human HOX genes (Genbank) using GCG-8 software (Genetics Computer
Group, Madison, WI).
RNA template labeling, probe preparation, and in situ hybridiz-
ation Templates for human HOXA4, HOXA5, HOXA7, HOXB4, HOXB7,
and HOXC4 were constructed by subcloning 39 nonhomeobox fragments in
Bluescript SK1 (Stratagene, La Jolla, CA). Linearized plasmids (1 µg) were used
to synthesize digoxigenin-labeled sense and anti-sense RNA probes (Boehringer,
Indianapolis, IN). RNA in situ hybridization was performed as described
(Mathews et al, 1993) with modifications to use digoxigenin labeled-probes
(Wilkinson, 1992). Sections were deparaffinized in three changes of Americlear
(Baxter Diagnostics, Deerfield, IL) and re-hydrated through graded ethanol.
Following washing, sections were digested with proteinase K (10 µg per ml)
for 30 min at 37°C, rinsed in physiologically buffered saline, washed in 0.1 M
triethanolamine with 0.25% acetic anhydride, prehybridized in 50% formamide,
2 3 sodium citrate/chloride buffer for 1 h at 37°C, and then allowed to air
dry. The digoxigenin-labeled probes were diluted in hybridization solution (2
3 sodium citrate/chloride buffer, 12.5 3 Denhardt’s solution, 50% formamide,
0.5% sodium dodecyl sulfate, 0.25 µg salmon sperm per ml, 0.5% sodium
pyrophosphate, 10 mM TrisHCl, pH 7.4), applied to each section, which was
then covered with parafilm and incubated overnight at 42°C. Sections were
washed, treated with RNAse A (20 µg per ml), washed in a series of increasing
1At the start of this project, 38 HOX genes had been described. As part of
this work, an additional human HOX gene was identified in developing dermis.
The new gene, HOXB13, appears to be differentially regulated in scarless fetal
wound healing and is the subject of a submitted manuscript (Stelnicki EJ,
Arbeit J, Cass DL, Saner C, Harrison M, Largman C: Changes in expression
of the human homeobox genes PRX-2 and HOXB13 are associated with
scarless fetal wound healing. Manuscript submitted). This gene was
independently isolated by Zeltser et al (1996) during these studies. The
degenerate primers used contained a match for the HOXB13 homeobox.
Figure 1. HOX homeobox genes are expressed in developing skin. (A)
PCR analysis, using degenerate primers designed to amplify a region of the
homeobox from any of the known 38 human HOX genes, was used to detect
HOX transcripts in whole second trimester fetal skin. Following an initial RT-
PCR amplification using oligo dT primers to generate an amplified cDNA, a
second round of PCR was performed with the degenerate primers to generate
a 118 bp DNA fragment (→, lane 2) reflecting the presence of HOX transcripts.
Lane 1 is an identical sample in which reverse transcriptase was omitted from
the initial cDNA synthesis step. (B) Identification of HOX gene transcripts in
whole skin samples. The 118 bp PCR products from each skin sample, prepared
as shown in (A), were cloned and sequenced, and comparison with published
sequences permitted identification of HOX transcripts. The values shown
represent the number of clones that matched a given HOX gene sequence.
Expression of the other 27 known human HOX homeobox genes was not
detected. (C) HOX genes were not detected in adult dermis. The degenerate
primer PCR method was also used to amplify HOX transcripts from fetal and
adult skin samples that have been split into epidermis and dermis. Appropriately
sized PCR products were detected in both fetal and adult epidermis (→, lanes
3 and 4), as well as in fetal dermis (lane 1); however, a 118 bp band was not
detected in the adult dermis (lane 2). Cloning and sequencing of the smeared
PCR products from the adult dermis confirmed that no HOX transcripts could
be detected. In contrast, the PCR bands for the fetal and adult epidermis and
the fetal dermis all gave data similar to those reported in (B).
stringency solutions, and rinsed in buffer (100 mM TrisHCl, pH 7.5, 150 mM
NaCl). Sections were incubated (1 h) in anti-digoxigenin-horseradish peroxidase
antibody (1:500) in buffer [1% non-fat dried milk, 0.5% fish skin gelatin,
10 mM 500 mM NaCl, 0.1% Tween 20, TrisHCl (pH 7.6)], then incubated
with biotinylated-tyramide (15 min), followed by a streptavidin-peroxidase
(15 min) (Dako, Carpinteria, CA). Signals were visualized with DAB chromogen
substrate (5 min). For some HOXA5 experiments, the color development time
was 25 min. To detect HOXA7 signals, color development was for 25 min and
a DAB color enhancer (Innovex Biosciences, Richmond, CA) was added to
the reaction. Some sections were counter-stained with hematoxylin to visualize
tissue morphology. Photographs were taken with a Nikon Microphot FX
photomicroscope and digitized using a Nikon Coolscan slide scanner. Composite
images were created with Adobe Photoshop, and printed on a Kodak dye
sublimation printer. Except for background color adjustment, no other image
processing was performed.
RESULTS
A subset of HOX homeobox genes is expressed in developing
human fetal skin We first used an RT-PCR/sequence analysis to
identify HOX homeobox genes expressed in human fetal and adult
scalp skin. With this method, an initial RT-PCR-amplified cDNA
library representing the total mRNA of each tissue sample was
constructed. This cDNA was then subjected to a second round of
PCR amplification using a set of degenerate PCR primers, derived
from conserved portions of the homeobox region, which were designed
to amplify all of the human HOX genes. Figure 1A shows a
representative experiment in which the expected 118 bp PCR product
band was detected in RNA isolated from whole second trimester fetal
scalp skin. The 118 bp PCR product band derived from each skin
sample was excised from the gel, cloned, and sequenced. Clones
containing HOX gene transcripts were identified by comparison with
published sequences of the 38 known HOX genes.1 When the PCR
products were cloned and identified, the majority of the HOX gene
transcripts detected in fetal skin (Fig 1B) belonged to the HOX A
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cluster. Of these, HOXA4, HOXA5, and HOXA7 appeared to be
predominant. Transcripts for HOXA6, HOXA10, HOXA11, and
HOXB7 were also detected with lower frequency in whole fetal skin.
It must be emphasized that it is not possible to use these data to
compare the relative levels of expression between time points. Like
the fetal tissue, the majority of HOX gene transcripts detected in the
human neonatal scalp were HOXA4, HOXA5, and HOXA7 (Fig 1B).
This same trend continued in the adult tissue, with the additional
detection of several members of the HOX-B cluster (HOXB1, HOXB3,
and HOXB6) and one member of the HOX-C locus (HOXC4)
(Fig 1B). The RT-PCR analysis was repeated on RNA isolated from
back and arm skin from first and second trimester embryos as well as
from newborn foreskin. These experiments revealed the same pattern
in which HOXA4, HOXA5, and HOXA7 were the major transcripts
detected (data not shown).
HOX gene transcripts are not detected in adult dermis by RT-
PCR A similar RT-PCR analysis was performed on fetal and adult
skin samples that were split into epidermis and dermis. Although the
expected 118 bp PCR band representing amplification of HOX
transcripts was detected in fetal epidermis and dermis, as well as in
adult epidermis, there was no apparent HOX gene expression in adult
dermis as reflected by the absence of the appropriate size PCR product
in multiple (N 5 5) samples (Fig 1C, lane 2). When the PCR bands
from the fetal epidermis and dermis and the adult epidermis were
cloned and sequenced, data similar to those shown in Fig 1B were
obtained (not shown). As anticipated by the lack of a 118 bp RT-
PCR band, cloning of the PCR products from adult dermis did not
yield identifiable HOX gene sequences.
HOXA4 is expressed in a temporal and spatial pattern during
epidermal development In order to obtain spatial localization of
HOX gene transcripts, we used in situ hybridization to analyze
expression during skin development. We analyzed HOX gene expres-
sion in skin from the scalp, back, and arm from first trimester (10 wk
estimated gestational age), early second trimester (14 wk estimated
gestational age), mid-second trimester (17 wk estimated gestational
age), and late second trimester (21 wk estimated gestational age)
embryos, as well as from normal newborn (4 mo old) and adult skin
samples. Because HOXA4, HOXA5, and HOXA7 appeared from the
RT-PCR data to be strongly expressed in developing skin, we first
examined expression of these genes at each developmental time point
(Fig 2). Because the signals for HOXA4 were quite strong, these
sections were counter-stained with hematoxylin to visualize tissue
morphology (Fig 2A–F). Weaker HOXA5 (Fig 2G–L) and HOXA7
(Fig 2M–R) signals were visualized on adjacent tissue sections without
counter-staining. In order to be able to compare HOXA4 expression
with that of the other genes, a subset of sections was also examined
for HOXA4 signals in the absence of counter-staining (Fig 3A–C).
HOXA4 was predominantly expressed in the basal cell layer, and was
localized to the lower layers of the developing epidermis in the early
(10 wk) embryonic skin (Figs 2A, 3A). Control slides in which tissues
were hybridized with a sense RNA probe were negative (see Fig 3R).
Cells of the periderm (present at 10 and 14 wk) did not express
HOXA4, or any other HOX gene studied. HOXA4 expression appeared
to gradually spread throughout the epidermis from 10 to 17 wk of
development until by mid-second trimester, the signal was detected in
the entire epidermis, except the stratum corneum (Figs 2B,C, 3B). It
should be noted that the stratum corneum was uniformly negative at
each developmental stage for every probe studied. By late second
trimester HOXA4 expression was less prevalent in the basal cell layer
but was still detected throughout the suprabasal epidermis (Figs 2D,
3C). HOXA4 expression was downregulated further in the basal and
stratum spinosum layers of the newborn (Fig 2E) and adult skin
(Fig 2F), where expression appeared to be localized to the upper
granular layers of the epidermis. The specimens shown in Fig 2(A–F)
were all from scalp except the 14 wk sample (Fig 2B) that was from
the back. In situ hybridization analysis of HOXA4 expression in the
corresponding series of back or arm skin samples showed essentially
identical temporal and spatial changes throughout development (data
not shown). In addition, the relative expression levels of HOXA4, as
well as those of the other HOX genes described below, did not vary
substantially between these three tissues during development.
HOXA4 expression is temporally regulated in the dermis during
skin development HOXA4 expression appeared to be virtually
absent in the dermis of first trimester (week 10, Figs 2A, 3A) and
early second trimester (week 14, Fig 2B) fetal skin; however, by mid-
second trimester (week 17, Figs 2C, 3B) HOXA4 expression was seen
in dermal fibroblasts. Weak expression persisted at late second trimester
dermis (week 21, Figs 2D, 3C), but was absent in newborn (Fig 2E)
and adult (Fig 2F) dermis. Fibroblasts in the dermal papillae did not
express HOXA4 or other HOX genes studied (Figs 2B–D, 3M, see
also the section on hair follicle development below).
HOXA5 and HOXA7 are expressed in similar patterns but at
lower levels than HOXA4 in developing skin In situ hybridization
experiments revealed that HOXA5 (Fig 2G–L) was detected at lower
levels but in a similar pattern to HOXA4, whereas initial experiments
with a HOXA7 probe gave very weak signals. We used increased color
development time and an additional amplification step in order to
localize expression of the HOXA7 gene (Fig 2M–R), which appeared
to follow similar temporal and spatial patterns to those observed for
HOXA4. Thus, expression appeared to move from the basal layers in
early epidermal development towards the outer epidermis in newborn
and adult skin. Weak expression of HOXA5 and HOXA7 was detected
in the fetal dermis during the second trimester of fetal development
(Fig 2I–O), but no expression of these genes was observed in newborn
(Fig 2K,Q) or adult dermis (Fig 2L,R).
HOXB4, HOXB7, and HOXC4 are variably expressed in devel-
oping skin We also used in situ hybridization to assess the expression
patterns of HOX genes detected at lower levels by the RT-PCR
method (HOXB7 and HOXC4), as well as a gene not detected by this
procedure (HOXB4). HOXC4 was expressed in similar temporal and
spatial patterns to those observed for HOXA4 (compare Fig 3J–L with
Fig 3A–C), whereas HOXB4 was barely detectable (compare Fig 3D–
F with 3R). HOXB7 was weakly expressed in the basal and suprabasal
layers of the 10 wk old skin (Fig 3G), was downregulated in early
second trimester skin (Fig 3H), and appeared to be upregulated
throughout the epidermis in 21 wk skin (Fig 3I). Expression of each
f these genes was downregulated and restricted to the upper epidermis
in newborn and adult skin (data not shown). Essentially identical results
were obtained using skin from either the back or the arm (not shown).
Differential HOX gene expression during hair follicle, sweat
gland, and sebaceous gland development As seen in Fig 2B,
early hair follicle formation was observed in the 14 wk skin. At this
time, none of the HOX genes studied could be detected in the
prospective bud (Fig 2B,H,N, and data not shown); however, by
17 wk, clear expression of HOXA4 (Figs 2C, 3B) and HOXA5 (Fig 2I)
was detected in developing follicles, whereas HOXC4 expression was
weak but noticeable (Fig 3K). None of the other HOX genes examined
were detected in the developing hair follicles of the 17 wk skin. By
21 wk, signals for HOXB7 in the maturing hair follicles (Fig 3I) were
approximately equal to those observed for HOXA4 (Figs 2D, 3C,
and 3M) or HOXC4 (Figs 3L and 3Q), whereas expression of the
other genes was not detected. In newborn skin, the mature follicles
showed expression of HOXA4 (Figs 3M and 3O), HOXA5 (Fig 3P),
and HOXA7 (Fig 2Q). More importantly, these HOX genes appeared
to be expressed in somewhat different spatial patterns in the mature
hair follicles in 21 wk and 4 mo skin. Thus HOXA4 (compare Figs 3M
and 3N, and see Fig 3O), HOXA7 (Fig 2Q), and HOXC4 (Fig 3Q)
were expressed in all the epidermal layers of the hair follicle but not
in the melanocytes or in the dermal papillae. In contrast, HOXA5
expression was restricted to the inner root sheath (Fig 3P). Only
extremely weak HOX gene expression was detected in the hair follicles
within the adult skin (data not shown). In addition to prevalent
expression in hair follicles, HOXA4 was clearly also expressed in sweat
glands in newborn skin (Fig 3O) and adult skin (data not shown).
Expression of the other HOX genes studied was not detected in sweat
glands at any stage of development. HOXA4 was also clearly detected
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Figure 2. HOXA4, HOXA5, and HOXA7 genes are
expressed in spatial and temporal patterns during skin
development. In situ hybridization analysis was used to
detect expression of HOXA4 (A–F), HOXA5 (G–L), and
HOXA7 (M–R) in serial sections from 10 wk scalp (A, G,
and M), 14 wk back (B, H, and N), 17 wk scalp (C, I, and
O), 21 wk scalp (D, J, and P), newborn scalp (E, K, and Q),
and adult scalp (F, L, and R). Parts (A)–(F) were counter-
stained with hematoxylin to visualize tissue morphology.
Parts (G)–(L) and (M)–(Q) represent adjacent sections to
those stained in (A)–(F). Digoxigenin-labeled RNA probes
were hybridized with tissue sections, and a tyramide
amplification and peroxidase detection was used to visualize
HOX gene expression as described in Materials and Methods.
Whereas detection of HOXA4 was visualized with 5 min
color development, HOXA5 was visualized at 25 min of
color development, and an additional color intensification was
also applied for HOXA7 signal detection. For comparison,
sections hybridized with a control sense RNA probe showed
no signal (see Fig 3R). All the → point to developing hair
follicles except the → in (L), which denotes the weak
expression of HOXA5 in the granular layer of the adult skin.
Scale bar, 100 µm.
in newborn and adult sebaceous glands, whereas expression of the
other HOX genes was not detected (data not shown).
DISCUSSION
The HOX homeobox genes appear to be important developmental
regulatory genes in animals as diverse as Drosophila to man (Krumlauf,
1992). These 39 genes encode transcription factors that appear to both
activate and repress embryonic gene expression. Given these roles in
other tissues, we and others have anticipated that the HOX genes
might play roles in skin development (Scott and Goldsmith, 1993).
Using a PCR-based screening method, the most commonly detected
HOX-gene transcripts in human skin were HOXA4, HOXA5, and
HOXA7. In addition, low level expression of several additional HOXA
and HOXB genes as well as the HOXC4 gene were detected by PCR
in the fetal or adult skin samples. In situ hybridization analysis confirmed
that HOXA4 was expressed at high levels in developing skin. In
addition, HOXC4 was expressed at high levels in developing skin
whereas HOXA5, HOXA7, and HOXB7 were expressed at lower
levels, and HOXB4 was barely detected. Our observations confirm
previous studies that have described detection of HOXA7 (Thomas
et al, 1989) and HOXB7 (Simeone et al, 1987) and localization of
HOXC4 expression to the suprabasal layer of normal adult human skin
(Reiger et al, 1994).
Taken together the two methods provide several important conclu-
sions concerning expression of HOX genes during skin development.
First, there appears to be a relatively conserved temporal and spatial
expression pattern shared by many of the HOX genes. Expression
appears to be limited to the basal cell layers in early skin development,
prevalent in the basal and stratum granulosum layers of the epidermis
as well as in the dermis during mid- to late second trimester develop-
ment, and dramatically downregulated and restricted to the granular
layers of the adult epidermis. No HOX gene expression was detected
in adult dermis by either RT-PCR or in situ hybridization analysis
among the subset of HOX genes analyzed. On the other hand, HOX
genes appear to be expressed in unique patterns in the developing hair
follicles. Secondly, the relative levels expression for the various HOX
genes appeared to be constant throughout development. The in situ
analysis showed, for instance, that HOXA4 was always detected at a
relatively high level in every tissue and time point analyzed, whereas
HOXB4 was only weakly expressed in each specimen examined. In
addition, the PCR analysis showed the three HOXA genes to be the
predominant genes detected at all time points studied.
It is unclear what the function(s) of the Hox proteins might be
during skin development. In other developmental programs, Hox
proteins appear to specify positional and timing information (Krumlauf,
1994). There have been several reports of differential HOX gene
expression patterns that support this type of role for Hox proteins in
skin and hair development (Chuong et al, 1990; Bieberich et al, 1991;
Kanzler et al, 1994); however, there is increasing evidence that enforced
expression of these genes in other tissues can lead to unregulated
proliferation (Aberdam et al, 1991; Maulbecker and Gruss, 1993;
Thorsteinsdottir et al, 1997), whereas loss of HOX gene expression is
associated with increased apoptosis.2 In the context of skin development,
HOX proteins might function as gene activators to upregulate cellular
proliferation in the early developing epidermis. Similar proliferative
2Izon DJ, Komuves LG, Rozenfeld S, Fong S, Largman C, Lawrence HJ:
Loss of function of the homeobox gene HoxA-9 retards T-cell development
and induces cell death. Manuscript submitted.
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Figure 3. Expression of HOXB4, HOXB7, and HOXC4
in developing skin. In situ hybridization analysis was
used to localize HOX homeobox gene expression during
embryonic skin development. For parts (A)–(L), expressions
in 10 wk (left panels), 17 wk (middle panels), and 21 wk (right
panels) scalp skin are shown. HOX genes studied were:
HOXA4 for comparison and for visualization in the absence
of hematoxylin counter-staining (A–C); HOXB4 (D–F);
HOXB7 (G–I); and HOXC4 (J–L). For parts (B)–(L), the
→ point to developing hair follicles. Expression of HOX
genes in hair follicles is also shown in (M)–(Q), as follows:
HOXA4 expression (black →) in a hair follicle from 21 wk
skin (M), the white → denotes the lack of expression in the
dermal papilla; the parallel section hybridized with a sense
control probe to show the background due to the developing
hair shaft (→) (N); HOXA4 expression in a hair follicle (black
→) and sweat glands (white →) from newborn skin (O);
HOXA5 expression in the inner root sheath (→) of the hair
follicle from newborn skin (P); HOXC4 expression in the
developing hair follicle (→) in 21 wk skin (Q). Part (R) was
hybridized with a control sense HOXA5 RNA probe.
Sections (A)–(L) were adjacent to those stained with
hematoxylin to visualize skin development shown in
Fig 2(A,C,D), respectively. Parts (M) and (O) were counter-
stained with hematoxylin to visualize morphologic structures.
Expression of these genes was visualized identically using a
standard 5 min color development. Scale bar, 100 µm.
functions might also be associated with the increased activity associated
with the dermis during second trimester skin development. In this
regard, it should be noted that first and early second trimester skin
possesses the capacity to heal wounds without scar formation, whereas
third trimester and adult skin lack this attribute (Weeks and Nath,
1993; Nath et al, 1995). It is possible that HOX proteins within the
dermis provide information for proper regeneration of the wound
during embryonic development. Finally, we hypothesize that HOX
proteins might function as repressors to downregulate cellular prolifera-
tion in the outer layers of the mature skin. Although few biologic
targets of HOX protein regulation have been identified, several of the
suggested targets of homeodomain protein action are cellular adhesion
or signaling molecules, which could play a role(s) in cellular proliferation
(Jones et al, 1992; White et al, 1992; Tomotsune et al, 1993).
The hypothetical roles described above would require HOX proteins
to act as activators in one cellular environment and as repressors in a
different cellular layer. One mechanism by which the HOX transcrip-
tion factors might exhibit different phenotypic effects is through the
presence or absence of partner proteins. We and others have recently
shown that HOX proteins form cooperative DNA binding complexes
with members of the PBX family of non-HOX homeodomain proteins
(Chang et al, 1995, 1996; Lu et al, 1995; Phelan et al, 1995; van Djik
et al, 1995). Furthermore, a recent model for HOX protein function
proposes that they cooperatively bind DNA as activators in the presence
of PBX and function as transcriptional repressors by binding alone to
DNA (Pinsonneault et al, 1997). Thus one model would be that the
HOX proteins might function as activators in early skin development
by binding DNA with PBX or other protein partners, and might
function as repressors in the granular cells of the adult epidermis if the
array of partner proteins was different in these cells.
It is somewhat puzzling that there appears to be such a high
redundancy of HOX gene expression in the developing skin. While
Hox genes are expressed in developing murine spinal cord or limb
buds in redundant, overlapping patterns, there are also apparent areas
in which individual Hox genes show increased relative expression
(Krumlauf, 1994). This does not appear to be the case in the developing
skin, because the expression patterns for the six HOX genes examined
appeared very similar. In addition, the expression of each gene appeared
to be relatively uniform across the body. Although the level of our
analysis was insufficient to determine if multiple HOX genes were
expressed in individual cells, it appears likely that there is a high level
of redundancy at the cellular level. Although this complexity is difficult
to interpret in terms of functional roles for the homeoproteins, it
should be noted that signaling molecules such as BMP-2 and BMP-4
(Francis et al, 1994), or the Wnt-like proteins (Parr and McMahon,
1994) that are thought to be both regulators and perhaps targets of
HOX proteins (Iler et al, 1995; Manak et al, 1995), are themselves
expressed in complex patterns throughout vertebrate development. In
addition, functional Hox gene redundancy in murine rhombomere
formation has recently been demonstrated (Gould et al, 1997). While
the purpose of this redundancy is not clear, we have recently demon-
strated large differences in complex stabilities between various HOX
proteins bound to DNA with PBX (Shen et al, 1997). We hypothesize
that the protein products derived from the HOX genes, which we
have demonstrated to be expressed in developing skin, function by
competing for DNA binding sites both as complexes with a variable
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set of partner proteins and as independent DNA binding proteins. As
a first step in defining the regulatory targets for HOX proteins in the
skin, it will be necessary to elucidate the set of DNA binding partners
expressed throughout skin development.
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